Objective Measures of Cochlear Implant Electrode Position and Function

Sponsor
Sophie McKenny (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04987684
Collaborator
University of Cambridge (Other)
30
1
1
13
2.3

Study Details

Study Description

Brief Summary

Recruit adult patients eligible for cochlear Implant surgery. During routine surgery monitor electrode placement with new 'SCINSEV' technique and complete 'PECAPs' on patient to identify if any of the electrodes have misplaced.

Follow up with patient after surgery for post operative appointment with same measurements.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: SCINSEV and PECAP
N/A

Detailed Description

Cochlear implants (CIs) restore hearing to deaf patients by electrically stimulating the auditory nerve using an array of electrodes inserted into the cochlea (inner ear). All electrodes should be successfully inserted in the cochlea, with each electrode exciting a discrete range of auditory nerve fibers.

Our research investigates two exceptions to this ideal situation, both of which impair the participant's ability to clearly hear sounds such as speech. One exception occurs when some electrodes are located outside the cochlea, limiting the amount of information that is conveyed to the brain and potentially causing unwanted side effects.

Our research will identify these extra-cochlear electrodes during the CI operation, by stimulating each electrode in turn and recording from all other electrodes.

This "SCINSEV" technique then uses a sophisticated computational method to identify which if any electrodes are out of the cochlea. Even when all electrodes are in the cochlea, however, some may produce broad current spreads, which will "blur" the perception of sounds. Our second "PECAP" method measures these instances by stimulating pairs of electrodes and recording the neural responses. It also uses a new computational method, this time so as to calculate the neural spread from each electrode.

Both methods use fast, non-invasive, objective measurements that use the built-in capabilities of the implant .The interventions used are very similar to those employed in standard clinical practice, and the results will pave the way for better identification and management of poor hearing by CI patients

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Objective Measures of Cochlear Implant Electrode Position and Function
Actual Study Start Date :
Dec 1, 2020
Anticipated Primary Completion Date :
Oct 1, 2021
Anticipated Study Completion Date :
Jan 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Standard of Care

Diagnostic Test: SCINSEV and PECAP
To measure PECAP and SCINSEVs. To find whether electrodes are outside of the cochlear or within dead regions within the cochlear.

Outcome Measures

Primary Outcome Measures

  1. Validation of extra cochlear electrodes [12 months]

    Number of extra-cochlear electrodes obtained using our "SCINSEV" analysis correspond to the actual number of extra-cochlear electrodes observed during different stages of insertion.

Secondary Outcome Measures

  1. Pre and post op loudness comparison [12 months]

    Numbers of neural dead regions and wide current spread estimated intra-operatively and using equal current per electrode using our "PECAP" method correspond to those occurring post-operatively and using equal loudness per electrode

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participant is willing or able to consent to participation in the study

  • Meets normal candidacy requirements for cochlear implantation

  • At least 18 years of age at time of consent being given

  • Patent cochlea as verified by CT or MRI scan

  • No additional complex needs that would prevent study procedures being followed

  • Agreement to participate in the study

Exclusion Criteria:
  • Using medication in a manner that might affect hearing levels

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cambridge University Hospitals NHS Foundation Trust Cambridge United Kingdom CB2 OQQ

Sponsors and Collaborators

  • Sophie McKenny
  • University of Cambridge

Investigators

  • Principal Investigator: Daniele Borsetto, Addenbrookes Hospital, CUH

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sophie McKenny, Clinical Researcher, Cambridge University Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT04987684
Other Study ID Numbers:
  • 285894
First Posted:
Aug 3, 2021
Last Update Posted:
Aug 25, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sophie McKenny, Clinical Researcher, Cambridge University Hospitals NHS Foundation Trust

Study Results

No Results Posted as of Aug 25, 2021